Serious Concerns Raised Over FDA Approved Monkeypox Vaccine
Credit: Getty Images
On August 30th, the FDA approved the ACAM2000 vaccine for monkeypox for individuals classified as high-risk for the infection. This move has raised significant alarm due to the potential risks that the vaccine poses.
The vaccine was created by Emergent Biosolutions and was previously approved for smallpox in 2007.
Following the recently approved expanded use of the drug, the FDA issued a statement mandating that all recipients of the ACAM2000 vaccine be provided with a copy of the FDA’s medication guide. They justified this requirement by claiming, “A medication guide is essential for the safe and effective use of the vaccine, as it can help prevent serious adverse events.”
The medication guide reveals troubling potential side effects,
